Riskpilot← Back to searchSign inGet full accessENDRE SOLVI AS
ASActiveOrg 889110902Rosenlund 51, 1617 FredrikstadGeneral medical practice activities · NACE 8621Est. 20062 employeeswww.rosenlundlegesenter.no
Revenue 2024
NOK 4,5M
+8% vs 2023
EBITDA margin
48.0%
+27% vs 2023
Equity ratio
93.2%
Financial strength
Net profit 2024
NOK 5,4M
+210% vs 2023
| Revenue | NOK 4,5M | +8% |
| EBITDA | NOK 2,1M | +27% |
| Net profit | NOK 5,4M | +210% |
| Total assets | NOK 15,2M | +52% |
| Equity | NOK 14,2M | +54% |
| Employees | 2 | — |
Legal name
ENDRE SOLVI AS
Org number
889110902
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
10. januar 2006
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Allmenn legepraksis, samt deltagelse i og utøvelse av annen virksomhet som måtte være av interesse for selskapet.
Address
Rosenlund 51, 1617 Fredrikstad
Website
www.rosenlundlegesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 948 | 2 368 | 2 463 | 2 678 | 3 049 | 3 032 | 3 088 | 3 109 | 3 090 | 3 447 | 3 358 | 3 691 | 3 494 | 3 963 | 3 909 | 4 114 | 4 451 |
| Staff expenses | −1 116 | −793 | −554 | −583 | −730 | −673 | −749 | −750 | −734 | −942 | −1 040 | −1 075 | −981 | −989 | −1 020 | −1 274 | −1 214 |
| EBITDA | 414 | 833 | 905 | 1 190 | 1 427 | 1 453 | 1 506 | 1 566 | 1 466 | 1 592 | 1 456 | 1 748 | 1 602 | 2 025 | 1 902 | 1 678 | 2 136 |
| Depreciation & amort. | −170 | −170 | −169 | −22 | −22 | −21 | −14 | −10 | −10 | −10 | −3 | −131 | −191 | −187 | −184 | −193 | −10 |
| EBIT | 244 | 663 | 736 | 1 168 | 1 405 | 1 432 | 1 492 | 1 556 | 1 455 | 1 582 | 1 453 | 1 618 | 1 412 | 1 838 | 1 718 | 1 485 | 2 126 |
| Net financials | 10 | 13 | −5 | −8 | −4 | 1 | 2 | 21 | 19 | 19 | −3 | 42 | 12 | 480 | 24 | 599 | 3 740 |
| Profit before tax | 253 | 676 | 730 | 1 159 | 1 401 | 1 433 | 1 494 | 1 577 | 1 474 | 1 601 | 1 450 | 1 660 | 1 423 | 2 318 | 1 741 | 2 084 | 5 865 |
| Tax | 72 | 189 | 207 | 325 | 393 | 403 | 405 | 428 | 370 | 387 | 334 | 365 | 313 | 409 | 385 | 352 | 501 |
| Net profit | 181 | 486 | 523 | 834 | 1 007 | 1 030 | 1 089 | 1 149 | 1 104 | 1 214 | 1 116 | 1 295 | 1 110 | 1 909 | 1 357 | 1 733 | 5 365 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 354 | 2 015 | 2 920 | 3 522 | 4 477 | 5 541 | 6 686 | 6 868 | 7 778 | 8 084 | 8 061 | 7 860 | 8 772 | 10 478 | 8 870 | 9 998 | 15 189 |
| Equity | 1 040 | 1 227 | 1 750 | 2 584 | 3 591 | 4 622 | 5 711 | 5 560 | 5 664 | 5 878 | 5 494 | 6 788 | 7 698 | 6 608 | 7 464 | 9 197 | 14 162 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 2 | 0 | 0 | 0 | 0 |
| Short-term debt | 313 | 788 | 1 170 | 938 | 885 | 919 | 976 | 1 308 | 2 114 | 2 206 | 2 567 | 1 065 | 1 072 | 3 871 | 1 406 | 801 | 1 027 |
| Total debt | 313 | 788 | 1 170 | 938 | 885 | 919 | 976 | 1 308 | 2 114 | 2 206 | 2 567 | 1 072 | 1 074 | 3 871 | 1 406 | 801 | 1 027 |
EBITDA margin
48.0%
This company
15.8%
Market median
+204% vs market
20082024
Equity ratio
93.2%
This company
38.2%
Market median
+144% vs market
20082024
Return on equity
37.9%
This company
18.4%
Market median
+106% vs market
20082024
Net profit margin
120.5%
This company
8.1%
Market median
+1388% vs market
20082024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20082024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20082024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ENDRE SOLVI AS 
ROSENLUND 51 EIENDOM ASBoard members of ENDRE SOLVI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Venke-Brit Pettersen Solvi | Board of Directors | 0 companies |
| Endre Solvi | Chairman | 0 companies |